Immutep, big on collaboration, not so much on out-licensing.....
Music to my ears......We need "Efti" for us.....diversifying collaborations
with different pharma is a means of self protection.....Marc Voight has
a well thought out business plan but more importantly it seems to be
being implanted to Immuteps benefit......We are an extremely well
managed company, that's half the battle.....
Immutep, big on collaboration, not so much on...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.005(1.56%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.5¢ | 31.5¢ | $465.8K | 1.452M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 587491 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 18585 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
